London, United Kingdom

William Garth Rapeport

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 7.9

ph-index = 8

Forward Citations = 319(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of William Garth Rapeport

Introduction

William Garth Rapeport is a notable inventor based in London, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating inflammatory disorders. With a total of 11 patents to his name, Rapeport's work has had a considerable impact on the pharmaceutical industry.

Latest Patents

Among his latest patents are the P38 MAP kinase inhibitors. These patents provide a compound of formula (I), wherein R, J, Ar, L, X, R, and R are defined in the specification, for use in the treatment of inflammatory disorders. This innovative approach showcases Rapeport's commitment to advancing medical treatments.

Career Highlights

Rapeport is currently associated with Respivert Limited, a company focused on developing novel therapies for respiratory diseases. His work at Respivert has allowed him to explore new avenues in drug development, contributing to the company's mission of improving patient outcomes.

Collaborations

Throughout his career, Rapeport has collaborated with esteemed colleagues such as Peter Strong and Kazuhiro Ito. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

William Garth Rapeport's contributions to the field of medicinal chemistry and his innovative patents highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in the treatment of inflammatory disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…